Dec 9, 2019
by
Wendy Meyer
In the fall of 2019, the FDA approved a new breakthrough therapy for cystic fibrosis (CF), a genetic disease that leads to lung, digestive, endocrine and nutritional problems. Researchers from Children’s Hospital Colorado were part of a national network that oversaw clinical trials leading to the approval of TRIKAFTA, a highly-effective treatment for people with CF, 12 years of age and older. The trials have taken place in the CCTSI’s pediatric Clinical and Translational Research Center (CTRC) at Children’s Colorado.
Full story